XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/news/ai-specialist-joins-genomics-englands-genomes-project/20%Daily2018-02-28 16:52
https://www.clinicaltrialsarena.com/news/painkilling-region-brain-provide-opioid-alternatives/20%Daily2018-02-28 10:50
https://www.clinicaltrialsarena.com/comment/patient-recruitment-solutions-for-rare-diseases-6068129-2/20%Daily2018-11-30 17:03
https://www.clinicaltrialsarena.com/news/obseva-reports-positive-phase-iii-data-implant2-trial/20%Daily2018-02-28 00:00
https://www.clinicaltrialsarena.com/news/study-finds-brexit-exclude-children-clinical-trials/20%Daily2018-02-28 00:00
https://www.clinicaltrialsarena.com/news/adverum-completes-dosing-phase-ii-trial-advm-043/20%Daily2018-02-28 00:00
https://www.clinicaltrialsarena.com/news/repurposed-cancer-drugs-reduce-disfigurements-children/20%Daily2018-02-27 18:03
https://www.clinicaltrialsarena.com/news/prokarium-raises-10m-thermostable-vaccines/20%Daily2018-02-27 16:57
https://www.clinicaltrialsarena.com/comment/verastems-duvelisib-seeks-fda-approval-relapsed-refractory-cll/20%Daily2018-02-27 14:11
https://www.clinicaltrialsarena.com/analysis/expert-insights-shires-breakthrough-therapy-maribavir-has-potential-to-shake-up-the-cytomegalovirus-market-6067384-2/20%Daily2019-08-09 11:17
https://www.clinicaltrialsarena.com/comment/aad-2018-outstanding-results-shown-new-psoriasis-biologic/20%Daily2018-02-27 10:53
https://www.clinicaltrialsarena.com/comment/imfinzi-activity-pd-l1-low-negative-recurrent-metastatic-head-neck-cancer-patients/20%Daily2018-02-27 10:41
https://www.clinicaltrialsarena.com/news/durect-starts-dosing-phase-lla-study-dur-928-psc/20%Daily2018-02-27 00:00
https://www.clinicaltrialsarena.com/news/bavarianto-initiate-phase-l-ll-trial-cv301-durvalumab/20%Daily2018-02-27 00:00
https://www.clinicaltrialsarena.com/comment/phase-ii-trials-dominate-2017/20%Daily2018-02-26 15:29
https://www.clinicaltrialsarena.com/news/first-child-receives-new-typhoid-conjugate-vaccine-malawi/20%Daily2018-02-26 15:20
https://www.clinicaltrialsarena.com/comment/continued-growth-glp-1-receptor-agonists-sglt-2-inhibitors-2017/20%Daily2018-02-26 14:06
https://www.clinicaltrialsarena.com/comment/immuno-oncology-clinical-trials-increased-17-average-yearly-growth/20%Daily2018-02-26 11:08
https://www.clinicaltrialsarena.com/news/ferring-msd-complete-champion-trial-treat-pph/20%Daily2018-02-26 00:00
https://www.clinicaltrialsarena.com/news/nei-initiates-new-study-examine-amd-progression/20%Daily2018-02-26 00:00
https://www.clinicaltrialsarena.com/news/jazz-enrols-first-patent-phase-ll-trial-defibrotide-agvhd/20%Daily2018-02-26 00:00
https://www.clinicaltrialsarena.com/news/oncopep-starts-phase-lb-trial-pvx-410-metastatic-tnbc/20%Daily2018-02-23 00:00
https://www.clinicaltrialsarena.com/news/daiichi-sankyo-begins-phase-l-trial-ds-1062/20%Daily2018-02-23 00:00
https://www.clinicaltrialsarena.com/news/centrexion-begins-phase-lll-trial-cntx-4975/20%Daily2018-02-23 00:00
https://www.clinicaltrialsarena.com/news/deals-week-ascendis-pharma-dandrit-biotech-usa-pangen-biotech/20%Daily2019-08-12 09:39
https://www.clinicaltrialsarena.com/news/mas-week-oncolys-biopharma-alira-health-nl-holding/20%Daily2018-02-23 00:00
https://www.clinicaltrialsarena.com/uncategorized/how-to-best-handle-electronic-trial-master-files-6058639-2/20%Daily2018-11-30 15:59
https://www.clinicaltrialsarena.com/comment/car-t-approvals-fuel-optimism-difficult-treat-disease/20%Daily2018-02-22 10:56
https://www.clinicaltrialsarena.com/news/abbvie-teams-voyager-develop-alzheimers-gene-therapy/20%Daily2018-02-22 10:12
https://www.clinicaltrialsarena.com/uncategorized/gsk-reports-positive-efficacy-data-fluarix-quadrivalent/20%Daily2019-08-12 10:22
https://www.clinicaltrialsarena.com/news/aimmune-reports-positive-results-palisade-trial/20%Daily2018-02-22 00:00
https://www.clinicaltrialsarena.com/news/vertex-start-phase-iii-trial-vx-659-tezacaftor-ivacaftor/20%Daily2018-02-22 00:00
https://www.clinicaltrialsarena.com/uncategorized/industry-viewpoints-exploring-the-benefits-of-machine-learning-in-clinical-trials-6058638-2/20%Daily2018-11-30 15:39
https://www.clinicaltrialsarena.com/comment/pants-study-supports-infliximab-biosimilar-use-crohns-disease/20%Daily2018-02-21 17:32
https://www.clinicaltrialsarena.com/comment/ecco-ibd-2018-can-takedas-entyvio-first-line-biologic-uc-treatment/20%Daily2018-02-21 14:20
https://www.clinicaltrialsarena.com/news/shire-eurordis-microsoft-announce-rare-disease-alliance/20%Daily2018-02-21 14:00
https://www.clinicaltrialsarena.com/news/nusinersen-offers-new-hope-children-spinal-muscular-atrophy/20%Daily2018-02-21 11:19
https://www.clinicaltrialsarena.com/news/celgene-announces-positive-data-behcets-disease-treatment/20%Daily2018-02-21 09:18
https://www.clinicaltrialsarena.com/news/vical-begins-phase-ii-trial-vl-2397-invasive-aspergillosis/20%Daily2018-02-21 00:00
https://www.clinicaltrialsarena.com/news/medicines-company-completes-enrolment-phase-iii-trial-inclisiran/20%Daily2018-02-21 00:00
https://www.clinicaltrialsarena.com/news/alltrials-urges-fda-fine-sponsors-missing-trial-results/20%Daily2018-02-21 00:00
https://www.clinicaltrialsarena.com/uncategorized/technology-use-in-drug-development-impact-on-outsourcing-process-and-people-6058637-2/20%Daily2018-11-30 15:37
https://www.clinicaltrialsarena.com/news/new-data-shows-long-term-benefit-janssens-psoriasis-treatment/20%Daily2018-02-20 17:03
https://www.clinicaltrialsarena.com/comment/whats-next-medical-cannabis-industry/20%Daily2018-02-20 15:59
https://www.clinicaltrialsarena.com/news/cell-therapy-receives-new-backing-japanese-firms/20%Daily2018-02-20 09:28
https://www.clinicaltrialsarena.com/news/celgene-reports-positive-phase-iii-results-otezla-trial/20%Daily2018-02-20 00:00
https://www.clinicaltrialsarena.com/news/aeras-reports-positive-phase-ii-results-trial-bcg-combination/20%Daily2018-02-20 00:00
https://www.clinicaltrialsarena.com/news/evolus-reports-positive-phase-iii-data-prabotulinumtoxina/20%Daily2018-02-20 00:00
https://www.clinicaltrialsarena.com/uncategorized/is-the-use-of-emerging-technologies-creating-blurred-lines-6058636-2/20%Daily2018-11-30 15:34
https://www.clinicaltrialsarena.com/comment/checkpoint-inhibitors-continue-show-benefits-range-tumours/20%Daily2018-02-19 12:00
https://www.clinicaltrialsarena.com/comment/bristol-myers-squibb-clinches-record-immuno-oncology-deal/20%Daily2018-02-19 11:47
https://www.clinicaltrialsarena.com/news/fda-looks-lower-requirements-alzheimers-drug-trials/20%Daily2018-02-19 10:57
https://www.clinicaltrialsarena.com/news/novartis-reports-positive-phase-iii-data-cosentyx/20%Daily2018-02-19 00:00
https://www.clinicaltrialsarena.com/news/birchbiomed-secures-approval-begin-phase-ii-trial-fs2/20%Daily2018-02-19 00:00
https://www.clinicaltrialsarena.com/news/wilson-enrols-first-patient-phase-iii-trial-wtx101/20%Daily2018-02-19 00:00
https://www.clinicaltrialsarena.com/news/industry-viewpoints-loves-labor-is-not-lost-introducing-clinical-maestro-6058635-2/20%Daily2018-11-30 15:24
https://www.clinicaltrialsarena.com/comment/announcing-clin-tech-week-on-clinical-trials-arena-6058632-2/20%Daily2018-11-30 15:20
https://www.clinicaltrialsarena.com/news/prostate-cancer-drug-given-approval-fda/20%Daily2019-08-09 08:40
https://www.clinicaltrialsarena.com/news/dbv-technologies-seeks-fda-approval-peanut-allergy-patch/20%Daily2018-02-16 11:10
https://www.clinicaltrialsarena.com/comment/the-age-of-immortality/20%Daily2022-03-24 10:13
https://www.clinicaltrialsarena.com/analysis/expert-insights-could-hospital-owned-generics-be-a-boon-to-cmos-6054138-2/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/mas-week-absolute-antibody-charles-river/20%Daily2019-08-12 09:39
https://www.clinicaltrialsarena.com/news/citius-enrols-first-patient-phase-iii-trial-mino-lok/20%Daily2018-02-16 00:00
https://www.clinicaltrialsarena.com/news/merck-pfizers-phase-iii-lung-cancer-trial-avelumab-fails/20%Daily2018-02-16 00:00
https://www.clinicaltrialsarena.com/news/deals-week-catalyst-biosciences-poxel-sa-bioxcel-therapeutics/20%Daily2018-02-16 00:00
https://www.clinicaltrialsarena.com/news/therachon-doses-first-patient-phase-l-trial-ta-46/20%Daily2018-02-16 00:00
https://www.clinicaltrialsarena.com/news/toolkit-aims-make-life-sciences-software-user-friendly/20%Daily2018-02-15 15:54
https://www.clinicaltrialsarena.com/comment/should-the-pharmaceutical-and-biotech-industries-be-investing-more-in-conservation-efforts-6057308-2/20%Daily2018-11-30 15:12
https://www.clinicaltrialsarena.com/news/new-drug-promises-eliminate-flu-virus-day/20%Daily2018-02-15 10:20
https://www.clinicaltrialsarena.com/news/ketone-drink-limits-spikes-blood-sugar/20%Daily2018-02-15 10:06
https://www.clinicaltrialsarena.com/news/bicycle-therapeutics-begins-dosing-phase-iia-trial-bt1718/20%Daily2018-02-15 00:00
https://www.clinicaltrialsarena.com/news/irx-therapeutics-doses-first-patient-phase-ll-trial-irx-2/20%Daily2018-02-15 00:00
https://www.clinicaltrialsarena.com/news/mallinckrodt-enrolls-first-patient-expressgraft-c9t1-phase-trial/20%Daily2018-02-15 00:00
https://www.clinicaltrialsarena.com/news/novartis-teams-gates-foundation-cryptosporidiosis-drug-candidate/20%Daily2018-02-14 15:40
https://www.clinicaltrialsarena.com/comment/back-future-old-antibiotic-compounds-offer-new-hope-fight-antibiotic-resistance/20%Daily2018-02-14 13:57
https://www.clinicaltrialsarena.com/comment/small-pharma-and-the-big-fight-creating-opportunities-for-dynamic-change-6054127-2/20%Daily2018-11-30 15:07
https://www.clinicaltrialsarena.com/news/fda-approves-vertexs-cystic-fibrosis-combo-therapy/20%Daily2018-02-14 11:17
https://www.clinicaltrialsarena.com/news/new-study-shows-decreased-nih-funding-drug-trials/20%Daily2018-02-14 00:00
https://www.clinicaltrialsarena.com/news/pulmatrix-doses-first-patient-phase-l-lb-trial-pulmazole/20%Daily2018-02-14 00:00
https://www.clinicaltrialsarena.com/news/merck-stop-phase-iii-study-verubecestat-prodromal-ad/20%Daily2018-02-14 00:00
https://www.clinicaltrialsarena.com/news/molecular-therapy-shown-combat-nerve-damage/20%Daily2018-02-13 16:05
https://www.clinicaltrialsarena.com/news/pieris-seattle-genetics-announce-immuno-oncology-partnership/20%Daily2018-02-13 11:23
https://www.clinicaltrialsarena.com/comment/clinical-vendor-inspections-setting-up-your-trial-for-success-with-pre-trial-vendor-qualification-6054093-2/20%Daily2018-11-30 15:05
https://www.clinicaltrialsarena.com/news/audentes-begins-dosing-patients-phase-l-ll-trial-at342/20%Daily2018-02-13 00:00
https://www.clinicaltrialsarena.com/news/diurnal-completes-enrolment-phase-iii-trial-chronocort-cah/20%Daily2018-02-13 00:00
https://www.clinicaltrialsarena.com/news/aveo-eusa-report-positive-data-fotivda-opdivo-trial/20%Daily2018-02-13 00:00
https://www.clinicaltrialsarena.com/news/nice-approves-treatment-advanced-renal-cell-carcinoma/20%Daily2018-02-12 16:42
https://www.clinicaltrialsarena.com/comment/exciting-trial-results-patients-lung-cancer/20%Daily2018-02-12 11:23
https://www.clinicaltrialsarena.com/news/two-compounds-found-block-transmission-malaria/20%Daily2018-02-12 11:03
https://www.clinicaltrialsarena.com/news/regenxbio-completes-dosing-third-cohort-phase-l-trial-rgx-314/20%Daily2018-02-12 00:00
https://www.clinicaltrialsarena.com/news/aerpio-completes-enrolment-phase-iib-trial-akb-9778-dr/20%Daily2018-02-12 00:00
https://www.clinicaltrialsarena.com/news/georgetown-reports-positive-phase-data-inlyta-keytruda/20%Daily2018-02-12 00:00
https://www.clinicaltrialsarena.com/news/fda-approves-zytiga-combo-castration-sensitive-prostate-cancer/20%Daily2019-08-09 08:40
https://www.clinicaltrialsarena.com/news/drug-shown-reverse-damaging-effects-alcohol-consumption/20%Daily2018-02-09 15:30
https://www.clinicaltrialsarena.com/comment/acne-time-new-approach/20%Daily2019-08-09 09:45
https://www.clinicaltrialsarena.com/comment/industry-viewpoints-outsourcing-in-medical-device-studies-6050210-2/20%Daily2018-11-30 15:03
https://www.clinicaltrialsarena.com/news/bonti-starts-phase-ll-trial-eb-001-scar-reduction/20%Daily2018-02-09 00:00
https://www.clinicaltrialsarena.com/news/viiv-initiates-phase-iii-study-tivicay-epivir-hiv-1/20%Daily2018-02-09 00:00
https://www.clinicaltrialsarena.com/news/deals-this-week-diffusion-celsion-sailing-capital/20%Daily2019-08-12 09:39
https://www.clinicaltrialsarena.com/news/yl-biologics-reports-positive-clinical-trial-rheumatoid-arthritis-drug/20%Daily2019-08-09 09:33
https://www.clinicaltrialsarena.com/news/mas-week-v-clinbio-proteomics-devonian-health-group/20%Daily2018-02-09 00:00
https://www.clinicaltrialsarena.com/news/heart-relaxation-drug-offers-hope-diastolic-dysfunction/20%Daily2018-02-08 16:52
https://www.clinicaltrialsarena.com/news/bms-announces-phase-iii-success-cancer-immunotherapy-combo/20%Daily2018-02-08 12:21
https://www.clinicaltrialsarena.com/analysis/expert-insights-merck-is-one-to-watch-in-2018-6050175-2/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/xcovery-starts-phase-ll-trial-ensartinib/20%Daily2018-02-08 00:00
https://www.clinicaltrialsarena.com/news/actiniumto-start-phase-trial-actimab-clag-m-combination/20%Daily2018-02-08 00:00
https://www.clinicaltrialsarena.com/news/synairgen-doses-first-patient-phase-ii-trial-sng001-copd/20%Daily2018-02-08 00:00
https://www.clinicaltrialsarena.com/comment/cancer-cachexia-trial-design-lack-consensus-endpoints/20%Daily2018-02-07 15:18
https://www.clinicaltrialsarena.com/news/umbilical-cord-stem-cells-treat-newborn-babies-heart-defects/20%Daily2018-02-07 12:52
https://www.clinicaltrialsarena.com/news/acticor-reports-positive-phase-results-trial-act017/20%Daily2018-02-07 00:00
https://www.clinicaltrialsarena.com/news/endo-initiates-two-phase-lll-trials-cch-treat-cellulite/20%Daily2018-02-07 00:00
https://www.clinicaltrialsarena.com/news/daiichi-sankyo-doses-first-patient-phase-l-trial-u3-1402/20%Daily2018-02-07 00:00
https://www.clinicaltrialsarena.com/news/new-insight-bipolar-disorder-help-develop-treatment/20%Daily2018-02-06 16:34
https://www.clinicaltrialsarena.com/comment/cd47-targeted-therapies-breast-cancer-mop/20%Daily2018-02-06 12:02
https://www.clinicaltrialsarena.com/comment/high-levels-unmet-need-across-supportive-care-indications/20%Daily2018-02-06 11:53
https://www.clinicaltrialsarena.com/comment/crohns-disease-burden-will-grow-fastest-france-among-7mm/20%Daily2018-02-06 11:34
https://www.clinicaltrialsarena.com/comment/oncology-clinical-trials-fail-meet-enrolment-targets-china/20%Daily2018-02-06 10:36
https://www.clinicaltrialsarena.com/analysis/dach-the-central-engine-of-european-clinical-research-6046637-2/20%Daily2019-08-08 09:43
https://www.clinicaltrialsarena.com/news/shield-reports-negative-phase-iii-results-study-feraccru/20%Daily2018-02-06 00:00
https://www.clinicaltrialsarena.com/news/palatin-begins-dosing-patient-phase-l-study-pl-8177/20%Daily2018-02-06 00:00
https://www.clinicaltrialsarena.com/news/january-2018-top-news-stories-drug/20%Daily2018-02-06 00:00
https://www.clinicaltrialsarena.com/news/cryoport-tigenix-partner-phase-ib-iia-trial-cx611/20%Daily2018-02-06 00:00
https://www.clinicaltrialsarena.com/news/leukaemia-drug-may-repurposed-fight-cancers/20%Daily2018-02-05 16:36
https://www.clinicaltrialsarena.com/news/the-top-5-january-2018-6046636-2/20%Daily2018-11-30 14:55
https://www.clinicaltrialsarena.com/news/miragen-reports-positive-phase-l-result-trial-mrg-106/20%Daily2018-02-05 00:00
https://www.clinicaltrialsarena.com/news/syndax-begin-phase-ib-study-durvalumab-sndx-6352/20%Daily2018-02-05 00:00
https://www.clinicaltrialsarena.com/news/tetra-receives-health-canada-approval-phase-lll-trial-ppp001/20%Daily2018-02-05 00:00
https://www.clinicaltrialsarena.com/comment/the-secrets-to-success-in-oncology-trials-6045364-2/20%Daily2018-11-30 14:53
https://www.clinicaltrialsarena.com/comment/how-to-recruit-and-retain-patients-for-oncology-trials-6045362-2/20%Daily2018-11-30 14:50
https://www.clinicaltrialsarena.com/comment/clinical-trials-oncology-biosimilars-indications-can-expect-approvals/20%Daily2018-02-02 10:18
https://www.clinicaltrialsarena.com/uncategorized/4-steps-to-prepare-for-gdpr-6045361-2/20%Daily2019-08-08 09:38
https://www.clinicaltrialsarena.com/comment/pfizer-axes-phase-myeloperoxidase-inhibitor-retains-nash-program/20%Daily2018-02-02 10:01
https://www.clinicaltrialsarena.com/news/deals-week-onconova-therapeutics-humorigin-biotechnology-zosano-pharma/20%Daily2019-08-12 09:39
https://www.clinicaltrialsarena.com/news/panacea-ends-enrolment-phase-l-trial-pan-301-1/20%Daily2018-02-02 00:00
https://www.clinicaltrialsarena.com/news/vertex-initiate-phase-lll-study-vx-659-vx-445/20%Daily2018-02-02 00:00
https://www.clinicaltrialsarena.com/news/imago-secures-fda-ind-approval-phase-l-ll-trial-img-7289/20%Daily2018-02-02 00:00
https://www.clinicaltrialsarena.com/comment/phase-iii-trials-lead-australia/20%Daily2018-02-01 11:43
https://www.clinicaltrialsarena.com/news/cancer-vaccine-eliminates-tumours-mice/20%Daily2018-02-01 09:55
https://www.clinicaltrialsarena.com/uncategorized/the-fundamentals-behind-effective-data-management-6039780-2/20%Daily2018-11-30 14:43
https://www.clinicaltrialsarena.com/news/zogenix-ends-enrolment-second-phase-lll-trial-zx008/20%Daily2018-02-01 00:00
https://www.clinicaltrialsarena.com/news/gemphire-begins-phase-lla-trial-gemcabene-paediatric-nafld/20%Daily2018-02-01 00:00
https://www.clinicaltrialsarena.com/news/kiadis-pharma-doses-last-patient-phase-ii-trial-atir101/20%Daily2018-02-01 00:00